Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.350
+0.100 (8.00%)
At close: May 12, 2025, 4:00 PM
1.348
-0.002 (-0.13%)
After-hours: May 12, 2025, 6:32 PM EDT
Sunshine Biopharma Employees
Sunshine Biopharma had 52 employees as of December 31, 2024. The number of employees increased by 8 or 18.18% compared to the previous year.
Employees
52
Change (1Y)
8
Growth (1Y)
18.18%
Revenue / Employee
$670,659
Profits / Employee
-$98,733
Market Cap
4.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SBFM News
- 6 days ago - Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market - Accesswire
- 21 days ago - Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion - Accesswire
- 5 weeks ago - Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - Accesswire
- 5 weeks ago - Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - Accesswire
- 5 weeks ago - Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga
- 5 weeks ago - Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer - Accesswire
- 5 weeks ago - Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year - Accesswire
- 7 weeks ago - Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada - Accesswire